ECSP088325A - Forma farmacéutica que contiene metocarbamol, meloxicam y betametasona - Google Patents
Forma farmacéutica que contiene metocarbamol, meloxicam y betametasonaInfo
- Publication number
- ECSP088325A ECSP088325A EC2008008325A ECSP088325A ECSP088325A EC SP088325 A ECSP088325 A EC SP088325A EC 2008008325 A EC2008008325 A EC 2008008325A EC SP088325 A ECSP088325 A EC SP088325A EC SP088325 A ECSP088325 A EC SP088325A
- Authority
- EC
- Ecuador
- Prior art keywords
- agents
- acute
- metocarbamol
- meloxicam
- pharmaceutical industry
- Prior art date
Links
- GNXFOGHNGIVQEH-UHFFFAOYSA-N 2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate Chemical compound COC1=CC=CC=C1OCC(O)COC(N)=O GNXFOGHNGIVQEH-UHFFFAOYSA-N 0.000 title abstract 2
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 title abstract 2
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 title abstract 2
- 229960002537 betamethasone Drugs 0.000 title abstract 2
- 229960001929 meloxicam Drugs 0.000 title abstract 2
- 230000001154 acute effect Effects 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 206010002556 Ankylosing Spondylitis Diseases 0.000 abstract 1
- 206010006811 Bursitis Diseases 0.000 abstract 1
- 201000005569 Gout Diseases 0.000 abstract 1
- 206010018634 Gouty Arthritis Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000000491 Tendinopathy Diseases 0.000 abstract 1
- 206010043255 Tendonitis Diseases 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000005713 exacerbation Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 239000008394 flocculating agent Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 239000006174 pH buffer Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 239000000375 suspending agent Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 201000004595 synovitis Diseases 0.000 abstract 1
- 201000004415 tendinitis Diseases 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención esta relacionada con la Industria farmacéutica en general y con la Industria farmacéutica preparadora de medicamentos para el tratamiento de casos agudos y exacerbaciones de pacientes con artritis reumatoide, espondilitis anquilosante, osteoartritis, alivio del dolor y la inflamación de artritis gotosa aguda, bursitis aguda y subaguda, tendinitis, sinovitis. La composición farmacéutica, objeto de esta solicitud esta caracterizada por metocarbamol, meloxicam y betametasona; uno o más agentes antiadherentes, uno o más agentes desintegrantes; uno o más agentes aglutinantes, uno o más agentes lubricantes, uno o más agentes diluentes, uno o más agentes saborizantes, uno o más agentes surfactantes, uno o más agentes humectantes, uno o más agentes agentes suspensores, uno o más agentes edulcorantes, uno o más agentes floculantes, uno o más agentes conservadores; uno o más agentes antimicrobianos; uno o más sistemas amortiguadores de pH, y uno o más solventes y/o vehículos; uno o más agentes tonificantes; uno o más agentes antioxidantes; uno o más agentes quelantes y cualquier otro aditivo necesario para la formulación .
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA05010505A MXPA05010505A (es) | 2005-09-29 | 2005-09-29 | Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP088325A true ECSP088325A (es) | 2008-05-30 |
Family
ID=37900028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2008008325A ECSP088325A (es) | 2005-09-29 | 2008-03-28 | Forma farmacéutica que contiene metocarbamol, meloxicam y betametasona |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1930003A1 (es) |
| BR (1) | BRPI0616764A2 (es) |
| CO (1) | CO6180423A2 (es) |
| EC (1) | ECSP088325A (es) |
| MX (1) | MXPA05010505A (es) |
| WO (1) | WO2007037666A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5325779B2 (ja) | 2007-06-14 | 2013-10-23 | 株式会社ポーラファルマ | 医薬組成物 |
| MX2007011003A (es) * | 2007-09-07 | 2009-03-09 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de un antiinflamatorio no esteroideo, un relajante muscular de accion central y un inhibidor de la interleucina-1, indicada para el tratamiento de la artritis reumatoide y enfermedades relacionada |
| MX2007011001A (es) * | 2007-09-07 | 2009-03-09 | World Trade Imp Export Wtie Ag | Composicion farmaceutica compuesta por la combinacion de un antiinflamatorio esteroideo y un relajante muscular indicada para el control y tratamiento de enfermedades inflamatorias musculoesqueleticas que se acompañan de contractura muscular. |
| US20100016265A1 (en) * | 2008-07-16 | 2010-01-21 | Qaiser Yusuf | Anti-inflammatory composition and method for preparation |
| ES3037313T3 (en) * | 2009-10-12 | 2025-09-30 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
| BRPI1103205A2 (pt) * | 2011-06-03 | 2014-02-25 | Eurofarma Lab Ltda | Composição farmacêutica oral e uso da composição farmacêutica oral |
| EP3116554A4 (en) * | 2014-03-14 | 2017-08-23 | Teva Pharmaceutical Industries Ltd. | Transmucosal delivery of laquinimod by oral patches |
| EP3838270B1 (en) * | 2018-08-13 | 2024-10-09 | Amézcua Amézcua, Federico | Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses |
| MX393662B (es) * | 2018-11-05 | 2025-03-24 | Federico Amezcua Amezcua | Composición farmacéutica que comprende la combinación de un inhibidor selectivo de la ciclooxigenasa 2 y un carbamato derivado de la guaifenesina para el tratamiento del dolor, inflamación y contractura muscular. |
| MX2018013893A (es) * | 2018-11-12 | 2019-05-13 | Productos Maver S A De C V | Composicion topica estable. |
| MX2019000312A (es) * | 2019-01-08 | 2019-10-09 | Federico Amezcua Amezcua | Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico. |
| WO2025078964A1 (en) * | 2023-10-10 | 2025-04-17 | Liqmeds Worldwide Limited | An oral liquid formulation of methocarbamol |
| US12390439B2 (en) * | 2023-10-10 | 2025-08-19 | Liqmeds Worldwide Limited | Oral liquid formulation of methocarbamol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997020551A1 (en) * | 1995-12-05 | 1997-06-12 | Adcock Ingram Limited | Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic |
| US20040204413A1 (en) * | 2001-01-26 | 2004-10-14 | Joaquina Faour | Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant |
-
2005
- 2005-09-29 MX MXPA05010505A patent/MXPA05010505A/es not_active Application Discontinuation
-
2006
- 2006-06-06 WO PCT/MX2006/000048 patent/WO2007037666A1/es not_active Ceased
- 2006-06-06 BR BRPI0616764-0A patent/BRPI0616764A2/pt not_active IP Right Cessation
- 2006-06-06 EP EP06769362A patent/EP1930003A1/en not_active Withdrawn
-
2008
- 2008-03-28 EC EC2008008325A patent/ECSP088325A/es unknown
- 2008-03-28 CO CO08030897A patent/CO6180423A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO6180423A2 (es) | 2010-07-19 |
| WO2007037666A1 (es) | 2007-04-05 |
| MXPA05010505A (es) | 2007-03-28 |
| EP1930003A1 (en) | 2008-06-11 |
| BRPI0616764A2 (pt) | 2011-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP088325A (es) | Forma farmacéutica que contiene metocarbamol, meloxicam y betametasona | |
| CL2017002482A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
| BR112012005970A2 (pt) | moduladores tricíclicos de proteína quinase | |
| BR112017026704A2 (pt) | uso | |
| BR112017018941B8 (pt) | Molécula de ligação a cd20, seu uso, composição e método in vitro para direcionar a morte mediada por complemento de uma célula que expressa cd20 | |
| CL2018000108A1 (es) | Moléculas de anticuerpo que se unen a cd22 | |
| EA201992504A1 (ru) | Ингибиторы magl на основе пиразола | |
| BR112015013123A2 (pt) | inibidores de beta-lactamase | |
| MX394895B (es) | Composiciones útiles para el tratamiento de infecciones por staphylococcus aureus. | |
| BR112016029318A2 (pt) | tratamento de mielomas | |
| MX2017009036A (es) | Composicion de cemento compatibilizada para el tratamiento de una formacion subterranea. | |
| IN2012DN03112A (es) | ||
| GT201700184A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
| SG179161A1 (en) | Tricyclic compounds and pharmaceutical uses thereof | |
| EA201890320A1 (ru) | Молекулы антител, которые связывают cd79 | |
| MX2020003581A (es) | Compuestos monobactamicos cromanos para el tratamiento de infecciones bacterianas. | |
| BR112015007938A2 (pt) | componente com rolha vedante e método para moldagem de um inserto de um componente | |
| CL2008000202A1 (es) | Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor. | |
| BR112019024566A2 (pt) | inibidores de pirazol magl | |
| CL2016000568A1 (es) | Compuestos derivados de 2h-indazol-2-il-n-hidroxi-2-metilsulfonil-2-metil-butanamida sustituidos o sus sales; sus composiciones farmacéuticas que los contiene y su uso para la prevención y/o tratamiento de infecciones bacterianas gram-negativas. | |
| BR112015029354A2 (pt) | Composição para prevenir ou tratar degradação de cartilagem, e uso de rutina | |
| CL2017002451A1 (es) | Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
| MX2020010446A (es) | Tratamiento de inhibicion de corrosion para fluidos agresivos. | |
| BR112015006727A8 (pt) | uso de uma composição farmacêutica | |
| MX2017014080A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. |